Morningstar

Viking Therapeutics Inc VKTX

Stock XNAS Rating as of Oct 23, 2026

News

Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026

PR Newswire Oct 21, 2026, 8:05:00 PM
Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity

PR Newswire Oct 14, 2026, 11:05:00 AM
Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

PR Newswire Oct 6, 2026, 11:05:00 AM
Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes

PR Newswire Sep 28, 2026, 8:30:00 PM
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm

PR Newswire Sep 28, 2026, 3:12:00 PM
Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

PR Newswire Sep 23, 2026, 8:32:00 PM
This GLP-1 drug helped people maintain their weight loss in a clinical trial - even for those taking it once a month

MarketWatch Sep 22, 2026, 8:27:00 PM
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial — Update

Global News Select Sep 22, 2026, 3:42:00 PM
Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens

PR Newswire Sep 22, 2026, 11:05:00 AM
Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire Sep 2, 2026, 8:05:00 PM
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

PR Newswire Jul 29, 2026, 8:05:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.